Losartan Effects on Emotion-memory Interaction
NCT04606225 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2020-10-28
Summary
The purpose of this study is to investigate whether a single dose of losartan (50 mg) can affect emotion-memory interaction in healthy humans and its underlying neural mechanisms.
Conditions
- Healthy
Interventions
- DRUG
-
Losartan
administration of losartan (50 mg) (oral) Cozaar Oral Tablet
- DRUG
-
Placebo Oral Tablet
administration of placebo (oral)
Sponsors & Collaborators
-
University of Electronic Science and Technology of China
lead OTHER
Principal Investigators
-
Benjamin Becker, PhD · University of Electronic Science and Technology of China
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 30 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-10-10
- Primary Completion
- 2021-12-31
- Completion
- 2022-03-31
Countries
- China
Study Locations
More Related Trials
-
Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease
NCT04149860 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Vortioxetine (Lu AA21004) on the Concentrations of Selected Neurotransmitters in Healthy Male Adults
NCT01299805 ·Status: COMPLETED ·Phase: PHASE1
-
An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease
NCT07153848 ·Status: RECRUITING
-
Lecanemab for Early Onset Familial Alzheimer's Disease
NCT06883019 ·Status: RECRUITING
-
GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer's Disease
NCT00414622 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Yi-Zhi-An-Shen Granules For Older Adults With Amnestic Mild Cognitive Impairment
NCT03601000 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Language and Memory in Patients With Alzheimer's Disease
NCT00593372 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease
NCT00104442 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Cohort Study of Patients With Early Alzheimer's Disease Treated With Lecanemab
NCT06741553 ·Status: RECRUITING
-
Acute Effect of Lorazepam on Brain Activity Measured by Magnetoencephalograpy (MEG) and Electroencephalography (EEG)
NCT01272778 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment
NCT00134953 ·Status: TERMINATED ·Phase: PHASE3
-
The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms
NCT01780519 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects
NCT06556966 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
NCT00200538 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer
NCT02553928 ·Status: COMPLETED ·Phase: PHASE4
-
The Mechanism of MicroRNAs Network in Alzheimer's Disease
NCT05055310 ·Status: COMPLETED
-
A Study of Seltorexant in Participants With Probable Alzheimer's Disease
NCT05307692 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease
NCT06995573 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue
NCT02996916 ·Status: UNKNOWN ·Phase: PHASE4
-
Influence of Luteolin for Two Weeks on Memory in Healthy Subjects
NCT06047899 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease.
NCT01117948 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia
NCT02972658 ·Status: TERMINATED ·Phase: PHASE3
-
Neuromodulation and Language Acquisition (Stage Ib)
NCT00102856 ·Status: SUSPENDED ·Phase: PHASE4
-
Rosiglitazone Effects on Cognition for Adults in Later Life
NCT00242593 ·Status: UNKNOWN ·Phase: PHASE2
-
INTERCEPTOR Project: From MCI to Dementia
NCT03834402 ·Status: COMPLETED